GXP-Storage®, a life sciences leader in compliant, visible and scalable material management, announced today the appointment of Chris Otto as an Independent Board Member, effective November 12, 2025....

Veteran brings over three decades of global clinical research experience to strengthen innovation and international expansion
RESEARCH TRIANGLE PARK, N.C.: GXP-Storage®, a life sciences leader in compliant, visible and scalable material management, announced today the appointment of Chris Otto as an Independent Board Member, effective November 12, 2025. With over three decades of global clinical research and development experience, Otto brings deep operational expertise from his career at Eli Lilly and Company, where he most recently served as Global Leader and Associate Vice President of Clinical Laboratory Sciences, including accountability for clinical imaging and connected devices.
Otto’s appointment advances GXP-Storage’s mission to simplify material management across the full clinical lifecycle. As decentralized and hybrid trials become the norm, the company’s purpose-built facilities and GXP-Guardian® digital platform provide sponsors with complete visibility, validated environments and audit-ready confidence across global research networks.
“Clinical trials are more complex than ever before, and our customers need partners that understand the regulatory and operational demands of global studies,” said Jeff Johnson, Founder and CEO of GXP-Storage. “Chris brings deep experience managing international clinical operations at scale. His insight will be invaluable as we expand our global capabilities and help sponsors reduce operational burden while maintaining full compliance.”
Otto held leadership positions across Clinical Data Sciences, Clinical Pharmacology, and R&D IT during his tenure at Eli Lilly and Company. He also spent five years in Japan, where he established Lilly Japan's Clinical Laboratory Sciences organization and led multiple R&D initiatives and functions. His experience spans clinical development strategy, operational excellence and international research coordination across therapeutic areas.
“What attracted me to GXP-Storage is their understanding that you can’t optimize materials in transit without equally optimizing them at rest,” said Otto. “Their integrated approach creates the visibility and control that sponsors need to protect irreplaceable samples while maintaining inspection readiness, an issue I saw time and again in global studies.”
GXP-Storage’s expanding footprint-including its acquisition of Qualogy Ltd in the UK’s Golden Triangle-and dual ISO 9001:2015 and ISO 20387:2018 certifications, establishes one of the most comprehensive quality frameworks in regulated material management.
About GXP-Storage
GXP-Storage is the trusted partner for regulated material management in life sciences. Combining purpose-built facilities with the validated GXP-Guardian® digital platform, the company delivers total custody, real-time visibility and audit-proven compliance across every temperature-from controlled ambient to cryogenic. Trusted by global pharma, biotech, CDMO and healthcare organizations, GXP-Storage transforms storage from a compliance risk into a strategic advantage. Learn more at www.gxp-storage.com.
Fonte: Business Wire
Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…
G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes
Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries
Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…
Algolia, the AI Search and Retrieval platform trusted by more than 18,000 businesses and millions of developers worldwide, today announced that Algolia…
Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration…
Chai Discovery, the AI company building a computer-aided design suite for molecules, today announced a collaboration with Eli Lilly and Company (Lilly)…
Revvity, Inc. (NYSE: RVTY) today announced a collaboration with Eli Lilly and Company (Lilly) that expands access to Lilly’s high-quality predictive models…